You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAM RTKs

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Clear-Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab, Ipilimumab)

Enrolling by invitation
  • Clear-Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson
Jan 23, 2022

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

    Recruiting
    • Urothelial Carcinoma
    • +4 more
    • Tucson, Arizona
    • +33 more
    May 21, 2021

    MammaPrint Value for Pre-menopausal Breast Cancer Patients

    Recruiting
    • Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 25, 2022

      Duchenne Muscular Dystrophy Trial in Worldwide (Tamoxifen, Matching )

      Completed
      • Duchenne Muscular Dystrophy
      • Garches, France
      • +10 more
      Dec 19, 2022

      Educational Problems Trial in Fujisawa (3D printing technology learning program)

      Recruiting
      • Educational Problems
      • 3D printing technology learning program
      • Fujisawa, Kanayama, Japan
        shonan keiiku Hospital
      Jan 12, 2023

      Melasma Trial in Karachi (TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C), Kligman formula (hydroquinone 4%,

      Active, not recruiting
      • Melasma
      • TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)
      • Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)
      • Karachi, Sindh, Pakistan
        JPMC
      Aug 25, 2023

      Biological Characteristics of Mesothelioma Patients

      Completed
      • Malignant Mesothelioma
        • Rozzano, Milano, Italy
        • +1 more
        Sep 8, 2022

        Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

        Recruiting
        • Cancer of the Colon
        • BLOOD AND TUMOR
        • Marseille, France
          Institut Paoli Calmettes
        Jul 12, 2023

        Neutrophil Extracellular Traps Formation in Breast Cancer

        Recruiting
        • Breast Carcinoma
        • Biospecimen Collection
        • Electronic Health Record Review
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 27, 2022

        Clear Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab)

        Active, not recruiting
        Has Results
        • Clear Cell Renal Cell Carcinoma
        • Houston, Texas
          MD Anderson Cancer Center
        Apr 27, 2021

        Burns, Hand Burn, Hand Grasp Trial in Al ?ayy Ath Thamin (device, behavioral, procedure, other)

        Active, not recruiting
        • Burns
        • +3 more
        • Light emitting diode therapy (LED therapy)
        • +3 more
        • Al Ḩayy Ath Thāmin, Giza, Egypt
          October 6 University Hospital
        May 6, 2022

        The Antiaggregation Monitoring (TAM) Registry

        Completed
        • Aspirin Causing Adverse Effects in Therapeutic Use
        • Measurement of platelet anti-aggregation
        • Fribourg, FR, Switzerland
          Service de Cardiologie, Hôpital Cantonal Fribourg
        Oct 14, 2021

        Depression, Anxiety, Stress, Psychological Trial in Irvine (C-STRESS)

        Completed
        • Depression
        • +3 more
        • C-STRESS
        • Irvine, California
          UCI
        Mar 9, 2023

        Transplant Associated Microangiopathy TAM Trial in France, Germany, United States (LFG316 active drug, Standard of care

        Terminated
        Has Results
        • Transplant Associated Microangiopathy TAM
        • LFG316 active drug
        • Standard of care treatment
        • Chapel Hill, North Carolina
        • +5 more
        Dec 9, 2020

        Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

        Active, not recruiting
        • Efficacy
        • Oral sotorasib + IV Panitumumab
        • Seoul, Korea, Republic of
          Korea University Anam Hospital
        Aug 14, 2023

        Tumors Trial (ABN401)

        Not yet recruiting
        • Neoplasms
        • (no location specified)
        May 21, 2023

        Non Metastatic Breast Cancer Trial in Lyon, Paris, Saint Herblain (tamoxifen)

        Completed
        • Non Metastatic Breast Cancer
        • Lyon, France
        • +2 more
        Mar 10, 2021

        Frozen Shoulder Trial in Taoyuan (Glenohumeral joint and subacromial space triamcinolone injections, App-assisted exercise,

        Recruiting
        • Frozen Shoulder
        • Glenohumeral joint and subacromial space triamcinolone injections
        • +2 more
        • Taoyuan, Taiwan
          Chang Gung Memorial Hospital
        Jul 31, 2023

        Leuprorelin 3M in Premenopausal Hormone Receptor-positive Breast

        Not yet recruiting
        • Hormone Receptor-positive Breast Cancer
        • AI or TAM
        • (no location specified)
        May 17, 2021

        Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

        Terminated
        Has Results
        • Chronic Lymphocytic Leukemia
        • +3 more
        • TP-0903
        • TP-0903 and ibrutinib combination therapy
        • Phoenix, Arizona
        • +5 more
        Apr 4, 2022